IDBI Bank Amrit Mahotsav deposits

IDBI Bank, a private sector lender, has announced revised interest rates for fixed deposits (FDs) under ₹2 crore, effective from April 1st, 2023. The bank has launched the “Amrit Mahotsav FD” scheme, offering attractive returns for both elderly individuals and the general public.

“Amrit Mahotsav FD” Scheme Details

Under the “Amrit Mahotsav FD” scheme, IDBI Bank offers different interest rates for elderly individuals and the general public. Retail investors who fall under the senior citizen category can avail a higher interest rate of 7.65%. For the general public, the bank provides an interest rate of 7.15% on their fixed deposits.

Revised Interest Rates for General Public and Senior Citizens

The bank guarantees interest rates on fixed deposits maturing in 7 days to 10 years. The revised interest rates for the general public range from 3.00% to 6.25%, while senior citizens can enjoy rates from 3.50% to 6.75% on their deposits.

IDBI Bank’s Updated FD Rates

The following table showcases the revised interest rates offered by IDBI Bank for fixed deposits under ₹2 crore:

Deposit Tenure (Days) General Public (%) Senior Citizens (%)
7 – 30 3.00 3.50
31 – 45 3.35 3.85
46 – 90 4.25 4.75
91 – 180 4.75 5.25
181 days – 1 year 5.00 5.50
1 year – 2 years 6.00 6.50
2 years – 3 years 6.50 7.00
3 years – 10 years 6.25 6.75

 Find More News Related to Banking

Piyush Shukla

Recent Posts

Women’s U19 T20 World Cup 2027 to Begin on January 21 in Bangladesh and Nepal

The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…

13 hours ago

World Iodine Deficiency Day 2026: Causes, Symptoms, Prevention and India’s NIDDCP

Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…

13 hours ago

Nigeria Reports Imported Case of Ebola Bundibugyo Virus Disease

There is an imported case of the Bundibugyo strain of the Ebola virus in the…

14 hours ago

DCGI Approves Zytorvi (Toripalimab) for Advanced Esophageal Cancer

On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…

15 hours ago

Ipsos Quality of Care Perception Index 2026: Malaysia Ranks First, India Third

India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…

15 hours ago

Jamnagar Refinery: Why India’s Oil Hub Matters to the World

Jamnagar is a coastal city in the state of the Gujarat and it is emerging…

16 hours ago